Navigation Links
Easier Treatment for Blood Clot

A pulmonary embolism is a fairly common condition that can be fatal. It is defined as an obstruction of a blood vessel in the lungs, usually due to a blood clot, //which blocks a coronary artery. While treatment is not always successful for a pulmonary embolism, a new study shows a new treatment is just as effective and easier to administer to patients than the current treatment.

According to the American Heart Association, about 600,000 Americans develop a pulmonary embolism annually; 60,000 die from one. The standard treatment for a pulmonary embolism is intravenous heparin requiring the patient to be monitored and hospitalized. Researchers conducted a study to see if a daily injection of the drug fondaparinux would be effective for patients with a pulmonary embolism.

The study included 2,213 patients who had a pulmonary embolism. The patients received either one of three doses of fondaparinux or a continuous intravenous infusion of heparin. Both of the drugs were given for five days. Researchers compared how the patients in each group did after three months and noted if they had a recurrent pulmonary embolism.

Researchers report only 42 of the 1,103 patients on fondaparinux had a recurrent problem compared to 56 of the 1,110 patients on the standard treatment. They also found major bleeding occurred in 1.3 percent of the patients on fondaparinux compared to 1.1 percent of the patients on heparin. The mortality rates after three months were similar in the two groups. About 15 percent of the patients on fondaparinux received the drug on an outpatient basis.

Study authors conclude treatment of pulmonary embolisms with fondaparinux is at least as effective and as safe as the standard treatment. They feel because of the simplicity in giving fondaparinux, it could become the first treatment of choice for many patients with a pulmonary embolism.
'"/>




Page: 1

Related medicine news :

1. Drug May Make Breathing Easier for Millions
2. Easier Dialysis for Kids
3. Easier Methods Required to Screen Insulin Resistance
4. Easier Methods Required to Screen Insulin Resistance
5. Adopting Easier Methods To Screen Insulin Resistance
6. Easier Tests To Detect Tuberculosis
7. Self Hypnotic Relaxation Makes Breast Biopsy Easier and Less Painful
8. Asthmatic Children Still Not Breathing Easier, Study Says
9. Advances in Treatment of Cataracts
10. Recommendations for Treatment of Blood Pressue
11. Treatment for Menieres disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... ... February 10, 2016 , ... MetLoop CEO Jay Southerland ... version at the International Roofing Expo in Orlando, Florida on February 17-19. , ... advanced weather technology in the hands of consumers, roofing contractors, manufacturers and distributors,” ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... and Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City ... interpreting (VRI). , For nearly 23 years, Heart City Health Center has provided ...
(Date:2/10/2016)... Huntington, NY (PRWEB) , ... February 10, 2016 ... ... web-based compliance tracking solution, The Guard, to associations of medical professionals throughout the ... HIPAA compliance, including security risk assessments, policies and procedures, employee training, regulatory updates, ...
(Date:2/10/2016)... ... ... Emergency rooms provide emergency care to stabilize critical health issues, but emergency dental ... at risk of losing a tooth or their smiles. Dr. Marine Martirosyan, dentist ... include:, , Avulsed or knocked-out teeth , Dislodged ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... VIEW, Calif. , Feb. 10, 2016 ... of a synergistic confluence of various technologies ... value propositions, previously unavailable. These opportunities create ... and convergence, in turn, drives the development ... entrepreneurial scenario is characterized by technology convergences, ...
(Date:2/10/2016)... , Feb. 10, 2016 Mast Therapeutics, ... novel, clinical-stage therapies for sickle cell disease and heart ... offering of 29,090,910 units at a price to the ... one share of the Company,s common stock and one ... stock at an exercise price of $0.42 per share. ...
(Date:2/10/2016)... 10, 2016 /PRNewswire/ - The President of New Venture ... release of an anti-radiation product from their Research ... in the treatment of cancer using radiation and ... assist in the healing of radiation burns, even ... protect only the healthy cells from radiation damage. ...
Breaking Medicine Technology: